McKesson (MCK)
(Real Time Quote from BATS)
$506.71 USD
-1.29 (-0.25%)
Updated Sep 23, 2024 10:24 AM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
- YR Estimate
- 03/31/2024
- 03/31/2023
- 03/31/2022
- 03/31/2021
- 03/31/2020
- Revenue - Line of Business (LOBR)
- Revenue: U.S. Pharmaceutical
- 278,739.00
- 240,616.00
- 212,149.00
- 189,274.00
- 183,341.00
- Revenue - Line of Business (LOBR)
- Revenue: Prescription Technology Solutions
- 4,769.00
- 4,387.00
- 3,864.00
- 2,890.00
- 2,705.00
- Revenue - Line of Business (LOBR)
- Revenue: Medical-Surgical Solutions
- 11,313.00
- 11,110.00
- 11,608.00
- 10,099.00
- 8,305.00
- Revenue - Line of Business (LOBR)
- Revenue: International
- 14,130.00
- 20,598.00
- 36,345.00
- 35,965.00
- 38,341.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: U.S. Pharmaceutical
- 3,315.00
- 3,106.00
- 2,879.00
- 2,717.00
- 2,671.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Prescription Technology Solutions
- 837.00
- 679.00
- 500.00
- 467.00
- 468.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Medical-Surgical Solutions
- 1,019.00
- 1,159.00
- 959.00
- 805.00
- 679.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: International
- 378.00
- 498.00
- -968.00
- 485.00
- 231.00
- Income - Line of Business (LOBI)
- Adjusted Operating Profit: Corporate
- -648.00
- -457.00
- -1,073.00
- -584.00
- -685.00